Advertisement

Growth Hormone pp 253-260 | Cite as

GH Effects on Cardiac Function

  • Jörgen Isgaard
Part of the Endocrine Updates book series (ENDO, volume 4)

Abstract

Although traditionally associated with regulation of somatic growth, body composition and metabolism, it has become increasingly evident that the GH/IGF-I axis is important for cardiac growth and function. Early observations in acromegalic patients included manifestations such as cardiomegaly. impaired cardiac performance and higher morbidity and mortality in cardiovascular diseases [1,2]. These findings together with more recent data of compromised cardiac function in adult patients with GH deficiency [3–5] have focused the attention to GH as a potentially important regulator of the cardiovascular system. Moreover, a recent study showing beneficial effects of GH treatment of patients with dilated cardiomyopathy has also led to the suggestion of GH as a possible future agent in the treatment of congestive heart failure [6].

Keywords

Growth Hormone Dilate Cardiomyopathy Cardiac Growth Systolic Wall Stress Growth Hormone Receptor Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Courville C, Mason VR. The heart in acromegaly. Arch Intern Med 1938;61:704–713.CrossRefGoogle Scholar
  2. 2.
    Bengtsson BÅ, Edén S, Ernest I, Odén A, Sjögren B. Epidemiology and longterm survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327–335.PubMedCrossRefGoogle Scholar
  3. 3.
    Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, Saccà L, Lombardi G. Cardiac Structure and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993;77:1658–1661.PubMedCrossRefGoogle Scholar
  4. 4.
    Amato G, CarellaC, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccà L, Bellastella A. J Clin Endocrinol Metab 1993;77:1671–1676.PubMedCrossRefGoogle Scholar
  5. 5.
    Caidahl K, Edén S, Bengtsson B-Å. Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 1994;40:393–400.CrossRefGoogle Scholar
  6. 6.
    Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B Saccà L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;334:809–814.PubMedCrossRefGoogle Scholar
  7. 7.
    Friberg P, Folkow B, Nordlander M. Structural adaptation of the rat left ventricle in response to changes in pressure and volume loads. Acta Physiol Scand 1985;125:67–79.PubMedCrossRefGoogle Scholar
  8. 8.
    Schunkert H, Jahn L, Izumo S, Apstein CS, Lorell BH. Localization and regulation of c-fos and c-jun proto-oncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci USA 1991;88:11480–11484.PubMedCrossRefGoogle Scholar
  9. 9.
    Simpson PC. Role of proto-oncogenes in myocardial hypertrophy. Am J Cardiol. 1988;62:13G–19G.PubMedCrossRefGoogle Scholar
  10. 10.
    Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van Bilsen M, O’Brien TX, Evans SM. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 1993;55:77–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Friberg P, Isgaard J, Wåhlander H, Wickman A, Guron G, Adams MA. Cardiac hypertrophy and related growth processes: The role of Insulin-like growth factor I. Blood Pressure 1995;4 (suppl 2):22–29.Google Scholar
  13. 13.
    Murphy LJ, Bell GI, Duckworth L, Friesen G. Identification, characterization and regulation of a rat complimentary deoxyribonucleic acid which encodes insulin-like growth factor I. Endocrinology 1987;121:684–691.PubMedCrossRefGoogle Scholar
  14. 14.
    Isgaard J, Nilsson A, Vikman K, Isaksson OGP. Growth hormone regulates the level of insulin-like growth factor I in rat skeletal muscle. J. EndocrinoL 1989;120:107–112.CrossRefGoogle Scholar
  15. 15.
    D’Ercole AJ, Stiles AD, Underwood LE. Tissue concentration of somatomedin-C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Nati Acad Sci USA 1984;81:935–939.CrossRefGoogle Scholar
  16. 16.
    Han VKM, D’Ercole AJ, Lund KP. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 1987;236:193–197.PubMedCrossRefGoogle Scholar
  17. 17.
    Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor I gene expression in left ventricular hypertrophy. Circulation 1994;89:799–809.PubMedCrossRefGoogle Scholar
  18. 18.
    Wåhlander H, Isgaard J, Jennische E, Friberg P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992;19:25–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Guron G, Friberg P, Wickman A, Brantsing C, Gabrielsson B, Isgaard J. Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension 1996;27 (part 2):636–642.PubMedCrossRefGoogle Scholar
  20. 20.
    Mirsky J. Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Handbook of Physiology. Chapter 14, Section 2, Volume I. American Physiological Society 1979:497–531.Google Scholar
  21. 21.
    Isgaard J, Wåhlander H, Adams MA, Friberg P. Increased expression of growth hormone receptor mRNA and insulin-like growth factor I mRNA in volume overloaded hearts. Hypertension 1994;23:884–888.PubMedCrossRefGoogle Scholar
  22. 22.
    Russell-Jones DL, Leach RM, Ward JPT, Thomas CR Insilin-like growth factor-I gene expression is increased in the right ventricle hypertrophy induced by chronic hypoxia in the rat. J. Endocrinol. 1993;10:99–102.Google Scholar
  23. 23.
    Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P. Upregulation of IGF-I IGF-I receptor and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol 1994;158:160–168.PubMedCrossRefGoogle Scholar
  24. 24.
    Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Card Vasc Res 1995;30:825–834.Google Scholar
  25. 25.
    Chen Y, Arner A, Bornfeldt KE, Uvelius B, Arnqvist HJ. Development of smooth muscle cell hypertrophy is closely associated with increased gene expression of insulin-like growth factor binding protein-2 and-4. Growth Regulation 1995;5:45–52.PubMedGoogle Scholar
  26. 26.
    Mathews LS, Engerg B, Norstedt G. Regulation of rat GH receptor gene expression. Biol Chem. 1989;264:9905–9910.Google Scholar
  27. 27.
    Ymer SI & Herington AC. Developmental expression of the growth hormone receptor gene in rabbit tissues. Mol Cell Endocrinol 1992;83:39–49.PubMedCrossRefGoogle Scholar
  28. 28.
    Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat. A combined in vivo and in vitro evaluation. Circulation 1996;93:800–809PubMedCrossRefGoogle Scholar
  29. 29.
    Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth improves cardiac performance in experimental performance. Circulation 1995;92:262–267.PubMedCrossRefGoogle Scholar
  30. 30.
    Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross Jr J. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619–627.PubMedCrossRefGoogle Scholar
  31. 31.
    Isgaard J, Kujacic V, Jermische E, Holmäng A, Sun XY, Hedner T, Hjalmarson Å, Bengtsson B-Å Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest 1997;27:517–525PubMedCrossRefGoogle Scholar
  32. 32.
    Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF. Beneficial effects of growth hormone and insulin-like factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharmacol. 1995;26:420–425.PubMedCrossRefGoogle Scholar
  33. 33.
    Shen YT, Wiedmann RT, Lynch JJ, Grossman W, Johnson RG. GH replacement fails to improve ventricular fonction in hypophysectomized rats with myocardiai infarction. Am J Physiol 1996;271:H1721–H1727PubMedGoogle Scholar
  34. 34.
    Cittadini A, Grossman J, Napoli R, Katz S, Strömer H, Smith R, Clark R, Morgan JP, Douglas P. Growth hormone attenuates early ventricular remodeling and improves cardiac function in rats with large myocardiai infarction. J Am College Cardiol 1997;29:1109–1116CrossRefGoogle Scholar
  35. 35.
    Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sönksen PH. Cardiac failure responding to growth hormone. Lancet 1989;1:838–839PubMedCrossRefGoogle Scholar
  36. 36.
    Frustaci A, Perrone GA, Gentiloni N, Russo MA. Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 1992;97:503–511PubMedGoogle Scholar
  37. 37.
    O’Driscoll JG, Green DJ, Ireland M, Kerr D, Larbalestier RI. Treatment of endstage cardiac Mure with growth hormone. Lancet 1997;349:1068–1068PubMedCrossRefGoogle Scholar
  38. 38.
    Volterrani M, Desenzani P, Lorusso R, d’Aloia A, Manelli F, Giustina A. Hemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1997;349:1067–1068PubMedCrossRefGoogle Scholar
  39. 39.
    Beer N, Tortoledo F, Beer R, Pinedo M. Beneficial effects of growth hormone in patients with congestive heart failure. Abstract ”Heart Failure’ 97, Cologne Germany 1997.Google Scholar
  40. 40.
    Turner H, Wass JAH. Growth hormone in the treatment of dilated cardiomyopathy. Letter to the Editor, N Engl J Med 1996;335:672–672Google Scholar
  41. 41.
    Frustaci A, Gentiloni N, Russo MA. Growth hormone in the treatment of dilated cardiomyopathy. Letter to the editor, N Engl J Med 1996;335:672–673Google Scholar
  42. 42.
    Isgaard J, Bergh C-H, Caidahl K, Lomsky M, Hjalmarson Å, Bengtsson B-Å. A placebo controlled study of growth hormone in patients with congestive heart failure. Submitted LancetGoogle Scholar
  43. 43.
    Mayoux E, Ventura-Clapier R, Timsit J, Béhar-Cohen F, Hoffman C, Mercadier J-J. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res 1993;72:57–64.PubMedCrossRefGoogle Scholar
  44. 44.
    Strömer H, Cittadini A, Douglas PS, Morgan JP. Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. Circ Res 1996;79:227–236.PubMedCrossRefGoogle Scholar
  45. 45.
    Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichini M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715–1721.PubMedCrossRefGoogle Scholar
  46. 46.
    Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger HM. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle I-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 1994;91:1686–1690.PubMedCrossRefGoogle Scholar
  47. 47.
    Saraste A, Pullkki K, Kallajoki, M, Henriksen K, Parvinen M, Voipio-Pulki LM. Apoptosis in human acute myocardiai infarction. Circulation 1997;95:320–323PubMedCrossRefGoogle Scholar
  48. 48.
    Narula J, Haider N, Virmani R, DiSalvo, TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart Mure. N Engl J Med 1996;335-1182–1189PubMedCrossRefGoogle Scholar
  49. 49.
    Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S. The Polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233–243PubMedCrossRefGoogle Scholar
  50. 50.
    Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449–1456PubMedCrossRefGoogle Scholar
  51. 51.
    Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86–107PubMedGoogle Scholar
  52. 52.
    Buerke M, Mohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor-I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci (USA) 1995;92:8031–8035CrossRefGoogle Scholar
  53. 53.
    Tivesten Å, Matejka G, Caidahl K, Brantsing C, Sun XY, Bengtsson B-Å, Hedner T, Isgaard J. Growth hormone and IGF-I effects on cardiac function and regulation of the Fas receptor in rats with experimental myocardial infarction. Abstract # Pl-126, 79th Annual Meeting of the Endocrine Society, June 11-14 1997, Minneapolis, USAGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Jörgen Isgaard
    • 1
  1. 1.Research Center for Endocrinology and Metabolism, Department of Internal MedicineSahlgrenska University HospitalGöteborgSweden

Personalised recommendations